NR3C2 and congestive heart failure: The most common antiplatelet used was aspirin (n = 34, 34%) while B- blockers (n = 73,73%), Mineralocorticoid Receptor Antagonists (MRA) (n = 78,78%) and Angiotensin Receptor Neprilysin Inhibitors (ARNI) (n = 61,61%) were the most routinely used chronic heart failure therapy among the study participants.